Oncology & Cancer

Rare cancer responds unusually well to new treatment

Vienna, Austria: Patients with advanced gastrointestinal neuroendocrine tumours (NETs) have limited treatment options and there are few oncologists who are specialised in this relatively rare disease. But now results from ...

page 3 from 10